Tetrabarbital
| Tetrabarbital | |
|---|---|
| Tetrabarbital-2d.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Tetrabarbital is a barbiturate derivative that has been used in medicine primarily for its sedative and hypnotic properties. It is a central nervous system depressant that works by enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor.
Pharmacology[edit]
Tetrabarbital acts as a positive allosteric modulator of the GABA_A receptor, which increases the inhibitory effects of GABA in the central nervous system. This results in a calming effect, making it useful for inducing sleep and reducing anxiety.
Medical uses[edit]
Tetrabarbital has been used in the past for the treatment of insomnia, anxiety disorders, and as a pre-anesthetic agent. However, due to the development of safer and more effective medications, its use has declined significantly.
Side effects[edit]
Common side effects of tetrabarbital include drowsiness, dizziness, and headache. More serious side effects can include respiratory depression, hypotension, and allergic reactions.
History[edit]
Barbiturates, including tetrabarbital, were first synthesized in the early 20th century and became widely used for their sedative and hypnotic effects. Over time, the development of benzodiazepines and other anxiolytics led to a decline in the use of barbiturates due to their potential for addiction and overdose.
Chemical structure[edit]
Tetrabarbital is a derivative of barbituric acid, with a chemical structure that includes a pyrimidine ring. The presence of an ethyl group and a 4-methylpent-3-en-1-yl group at the 5-position of the ring distinguishes it from other barbiturates.
Synthesis[edit]
The synthesis of tetrabarbital involves the reaction of barbituric acid with appropriate alkylating agents to introduce the ethyl and 4-methylpent-3-en-1-yl groups.
Regulation[edit]
Due to its potential for abuse and dependence, tetrabarbital is classified as a controlled substance in many countries. Its use is restricted to specific medical indications and is subject to regulatory oversight.
Related pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
